Gleevec Keeps a Leukemia in Check for More Than a Decade: Study

WEDNESDAY, March 8, 2017 -- The cancer drug Gleevec appears to keep chronic myeloid leukemia at bay a decade into treatment -- with no signs of additional safety risks, a new study finds. Gleevec -- known generically as imatinib -- was hailed as a...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news